Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a backend/template update. No changes to the study text or user-facing elements are implied by this revision.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page content.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:24.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows 'No longer looking for participants' under enrollment and adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment label formatting and includes a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:43:57.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.5, indicating a small update to the site, with no visible changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This change updates the page's version metadata rather than its visible content or behavior.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:39.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page’s UI/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.